E-cadherin promoter methylation can regulate its expression in invasive ductal breast cancer tissue in Chinese woman

被引:19
作者
Hu, XC [1 ]
Loo, WTY [1 ]
Chow, LWC [1 ]
机构
[1] Univ Hong Kong, Med Ctr, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China
关键词
E-cadherin gene; western blotting; methylation-specitic PCR; CpG island;
D O I
10.1016/S0024-3205(02)01843-X
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Promoter methylation is an important mechanism of regulating E-cadherin expression. Methylation-specific PCR (MSP) assay was done to evaluate the promoter methylation status of E-cadherin gene in primary tumor samples from 23 cases of Chinese women with invasive ductal breast cancers. Western blotting assay was employed for E-cadherin and beta-actin expressions. Positive MSP results occurred in 26.1% (6/23) of primary tumor samples and none of four normal skin samples. These molecular events tended to occur in breast cancers associated with poor prognosis. Whereas the mean ratio of CDH1/beta-actin for six MSP-positive cases was 0.0290 +/- 0.0355, the mean ratio for 17 MSP-negative cases was 0.4726 +/- 0.5049 (P = 0.046). In conclusion, aberrant E-cadherin methylation preferentially occurs in invasive ductal breast cancer associated with poor prognosis and is one of the mechanisms of E-cadherin expression silence in breast cancers from Chinese women. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1397 / 1404
页数:8
相关论文
共 36 条
[1]  
BAYLIN SB, 1992, AIDS RES HUM RETROV, V8, P811
[2]  
Becker I, 1999, Verh Dtsch Ges Pathol, V83, P233
[3]   Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody [J].
Becker, KF ;
Kremmer, E ;
Eulitz, M ;
Becker, I ;
Handschuh, G ;
Schuhmacher, C ;
Müller, W ;
Gabbert, HE ;
Ochiai, A ;
Hirohashi, S ;
Höfler, H .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) :1803-1809
[4]   p15INK4B CPG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing [J].
Cameron, EE ;
Baylin, SB ;
Herman, JG .
BLOOD, 1999, 94 (07) :2445-2451
[5]  
Charpin C, 1999, INT J ONCOL, V15, P285
[6]  
Chow LWC, 1997, CHINESE MED J-PEKING, V110, P474
[7]  
Esteller M, 1999, CANCER RES, V59, P67
[8]   BRCA1 and E-cadherin promoter hypermethylation and gene inactivation in cancer-association or mechanism? [J].
Fearon, ER .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (07) :515-517
[9]  
Gonzalez MA, 1999, J PATHOL, V187, P523, DOI 10.1002/(SICI)1096-9896(199904)187:5<523::AID-PATH296>3.0.CO
[10]  
2-3